Department of Immunology, Portuguese Institute of Oncology, Porto, and Health School of University Fernando Pessoa, Porto, Portugal.
Urol Oncol. 2011 Mar-Apr;29(2):205-11. doi: 10.1016/j.urolonc.2009.07.022. Epub 2009 Oct 24.
To investigate whether carcinoma in situ (CIS) lesion could be considered a surrogate marker of urothelium genetic instability and field carcinogenesis or not, we evaluated DNA content, p53 overexpression, and proliferative index (Ki-67 expression) in primary tumor, in tumor-adjacent mucosa, and distant urothelial mucosa with and without presence of CIS.
A retrospective study in radical cystectomy specimens from 49 patients was carried out. All the lesions present in each cystectomy specimen were studied, including the tumor area and the adjacent mucosa (AM). Whenever possible, the distant mucosa (DM) was also studied. When CIS was detected, this lesion and the surrounding normal mucosa were also studied. The 49 tumor areas included high grade papillary urothelial carcinoma (HGP) in 19 cases (38.8%) and invasive urothelial cell carcinomas in 30 cases (61.2%). The nuclear DNA content of cancer cells was evaluated using image cytometry allowing the determination of the DNA ploidy and 5cER parameters. The p53 and Ki-67 immunoexpression was evaluated by immunohistochemistry.
CIS lesions were observed in the AM and DM of both tumor groups: 15.8% and 15.4% in AM and DM, for each one of them, in HGP group and 26.7% and 22.2% in AM and DM, for each one of them, in invasive tumors group. In CIS lesion aneuploid DNA content, p53 overexpression and high proliferative labeling index were observed. The so-called normal mucosa (AM and DM) with and without focus of CIS lesions were compared for genetic instability and molecular alterations profile. Statistical differences were observed between the normal mucosa with and without CIS: the so-called normal mucosa areas with focus of CIS revealed significantly higher frequencies of DNA content alterations, p53 overexpression, and higher proliferative index. These differences were significantly different in the invasive UCC group, but this profile it is also present in HPG group.
This study points out that CIS is a marker of genetic instability of the urothelium mucosa. The CIS surrounding morphologically normal urothelium showed a high frequency of abnormal DNA content, with high percentage of clear aneuploid cells (high 5cER), p53 mutated protein expression, and a proliferative status underlying a field carcinogenesis. These alterations in normal mucosa were not found when CIS was not present.
为了研究原位癌(CIS)病变是否可以被视为尿路上皮遗传不稳定性和癌前病变的替代标志物,我们评估了原发性肿瘤、肿瘤毗邻黏膜和无 CIS 存在的远处尿路上皮黏膜中的 DNA 含量、p53 过表达和增殖指数(Ki-67 表达)。
对 49 例根治性膀胱切除术标本进行了回顾性研究。研究了每个膀胱切除标本中的所有病变,包括肿瘤区域和毗邻黏膜(AM)。只要可能,还研究了远处黏膜(DM)。当检测到 CIS 时,还研究了该病变及其周围正常黏膜。49 个肿瘤区域包括 19 例高级别乳头状尿路上皮癌(HGP)(38.8%)和 30 例浸润性尿路上皮细胞癌(61.2%)。使用图像细胞术评估癌细胞的核 DNA 含量,允许确定 DNA 倍性和 5cER 参数。通过免疫组织化学评估 p53 和 Ki-67 的免疫表达。
在肿瘤组的 AM 和 DM 中观察到 CIS 病变:HGP 组中 AM 和 DM 中的 CIS 病变分别为 15.8%和 15.4%,浸润性肿瘤组中 AM 和 DM 中的 CIS 病变分别为 26.7%和 22.2%。在 CIS 病变中观察到非整倍体 DNA 含量、p53 过表达和高增殖标记指数。比较了有和无 CIS 病变的所谓正常黏膜(AM 和 DM)的遗传不稳定性和分子改变谱。在有和无 CIS 的正常黏膜之间观察到统计学差异:具有 CIS 焦点的所谓正常黏膜区域显示出更高频率的 DNA 含量改变、p53 过表达和更高的增殖指数。在浸润性 UCC 组中,这些差异具有显著意义,但在 HPG 组中也存在这种情况。
本研究指出,CIS 是尿路上皮黏膜遗传不稳定性的标志物。形态学正常的尿路上皮周围的 CIS 显示出高频率的异常 DNA 含量,高百分比的清晰非整倍体细胞(高 5cER)、突变型 p53 蛋白表达以及潜在的癌前病变的增殖状态。当没有 CIS 时,在正常黏膜中未发现这些改变。